San Diego, United States
dRx Capital AG is a joint venture investment company launched by Novartis and Qualcomm with a capital commitment up to $100M. We strive to catalyze the success of digital medicine products, services and business models by investing in early-stage companies and leveraging our extensive networks in Pharma, Mobile/IT, and investment community.
22
Total Investments
14
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Health Care, Pharmaceutical
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About dRx Capital
Recent Investments (22)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Jun 2022 | |
| Series C | •••••• | Feb 2022 | |
| Series C | •••••• | Nov 2021 | |
| Series C | •••••• | Sep 2021 | |
| Series A | •••••• | Jun 2021 | |
•••• ••••
|
Series B | •••••• | Feb 2021 |
|
•••• ••••
|
Seed Round | •••••• | Jan 2021 |
|
•••• ••••
|
Series B | •••••• | Dec 2020 |
|
•••• ••••
|
Series B | •••••• | Sep 2020 |
|
•••• ••••
|
Series A | •••••• | Mar 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
